Search

EHA Kick-off Grant review and selection process

1. Eligibility checkAfter the deadline has passed, we'll check your application for completion and compliance with the eligibility criteria.

Read more

Pomalidomide prolongs survival in refractory myeloma patients

MM-003 is a large, multi-centre phase 3 study that assessed the efficacy and safety of a new drug, Pomalidomide (POM) in combination with low-dose dexamethasone (POM+LoDex) and compared this combination with high dose dexamethasone in MM patients with late stage…

Read more

EHA-BMSH joint membership

Save money and time by becoming a joint member of EHA and the Bulgarian Medical Society of Hematology. We've joined forces with the Bulgarian Medical Society of Hematology (BMSH) to offer a special joint membership deal.

Read more